Previous Article | Next Article ![]()
Infection and Immunity, November 1999, p. 5951-5957, Vol. 67, No. 11
Laboratory of Parasitic Diseases, National
Institute of Allergy and Infectious Diseases, National Institutes of
Health, Bethesda, Maryland 20892,1 and
Department of Clinical Investigations,
Received 28 April 1999/Returned for modification 16 June
1999/Accepted 12 August 1999
To investigate whether helminth infections may affect the efficacy
of vaccines by impairing the immune response to nonparasite vaccine
antigens, we compared the antibody responses to tetanus toxoid (TT)
after tetanus vaccination in 193 subjects with Onchocerca volvulus infection with 85 comparable noninfected controls. After vaccination, the proportions of subjects in each group attaining protective levels of antitetanus antibodies were similar (96.9% infected versus 97.6% noninfected). Postvaccination increases in
antitetanus immunoglobulin G (IgG) and the predominant IgG isotype,
IgG1, were equivalent in both groups, as were increases in specific
IgG4 and IgE; however, significantly greater increases in specific IgG2
(P < 0.05) and IgG3 (P < 0.001)
were observed in the noninfected group. Stratification of the O. volvulus-infected group into two groups representing light and
heavy infections revealed a significantly impaired antitetanus IgG
response in those with heavy infections compared to those with light
infections (P < 0.01) or no infection
(P < 0.05). The impact of concurrent intestinal
helminth infections on the antitetanus response was also examined; an
increased IgG4/IgE ratio was seen in those infected with
Strongyloides stercoralis (P < 0.05) and
when all helminth infections were combined as a single group
(P < 0.05). These findings indicate that concurrent
infection with O. volvulus does not prevent the development
of a protective antitetanus response, although heavier O. volvulus infections are able to alter the magnitude of this
response, and concurrent helminth infections (O. volvulus and intestinal helminths) may alter TT-specific antibody isotype responses.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Human Onchocerciasis and Tetanus Vaccination:
Impact on the Postvaccination Antitetanus Antibody Response
*
Corresponding author. Mailing address: Laboratory of
Parasitic Diseases, NIAID, Bldg. 4, Rm. 126, National Institutes of
Health, 4 Center Dr., Bethesda, MD 20892-0425. Phone: (301) 496-0143. Fax: (301) 480-3757. E-mail: pcooper{at}niaid.nih.gov.
Infection and Immunity, November 1999, p. 5951-5957, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»